ATE274920T1 - Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen - Google Patents
Verwendung von anti-il-12 antikörpern bei transplantationsabstossungenInfo
- Publication number
- ATE274920T1 ATE274920T1 AT98956450T AT98956450T ATE274920T1 AT E274920 T1 ATE274920 T1 AT E274920T1 AT 98956450 T AT98956450 T AT 98956450T AT 98956450 T AT98956450 T AT 98956450T AT E274920 T1 ATE274920 T1 AT E274920T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies
- transplant rejection
- antibody
- administration
- alone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6385397P | 1997-10-31 | 1997-10-31 | |
| PCT/US1998/023264 WO1999022766A2 (en) | 1997-10-31 | 1998-10-30 | Use of anti-il-12 antibodies in transplantation rejection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE274920T1 true ATE274920T1 (de) | 2004-09-15 |
Family
ID=22051951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98956450T ATE274920T1 (de) | 1997-10-31 | 1998-10-30 | Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0969867B1 (de) |
| AT (1) | ATE274920T1 (de) |
| AU (1) | AU744302B2 (de) |
| CA (1) | CA2276420A1 (de) |
| DE (1) | DE69825976T2 (de) |
| WO (1) | WO1999022766A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6914128B1 (en) | 1999-03-25 | 2005-07-05 | Abbott Gmbh & Co. Kg | Human antibodies that bind human IL-12 and methods for producing |
| US7883704B2 (en) | 1999-03-25 | 2011-02-08 | Abbott Gmbh & Co. Kg | Methods for inhibiting the activity of the P40 subunit of human IL-12 |
| CN104524567A (zh) | 2007-01-16 | 2015-04-22 | 阿布维公司 | 用于治疗银屑病的方法 |
| CA2681752A1 (en) | 2007-03-29 | 2008-10-09 | Abbott Laboratories | Crystalline anti-human 1l-12 antibodies |
| EP2220120A2 (de) | 2007-11-27 | 2010-08-25 | Ablynx N.V. | Gegen heterodimere cytokine und/oder deren rezeptoren gerichtete aminosäuresequenzen, und polypeptide, die diese enthalten |
| EP2274333A4 (de) | 2008-03-18 | 2011-06-15 | Abbott Lab | Verfahren zur behandlung von psoriasis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK122199A3 (en) * | 1997-03-18 | 2000-12-11 | Basf Ag | Methods and compositions for modulating responsiveness to corticosteroids |
-
1998
- 1998-10-30 CA CA002276420A patent/CA2276420A1/en not_active Abandoned
- 1998-10-30 EP EP98956450A patent/EP0969867B1/de not_active Expired - Lifetime
- 1998-10-30 DE DE69825976T patent/DE69825976T2/de not_active Expired - Fee Related
- 1998-10-30 AT AT98956450T patent/ATE274920T1/de not_active IP Right Cessation
- 1998-10-30 WO PCT/US1998/023264 patent/WO1999022766A2/en not_active Ceased
- 1998-10-30 AU AU12974/99A patent/AU744302B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2276420A1 (en) | 1999-05-14 |
| WO1999022766A3 (en) | 1999-08-05 |
| EP0969867A2 (de) | 2000-01-12 |
| AU1297499A (en) | 1999-05-24 |
| WO1999022766A2 (en) | 1999-05-14 |
| EP0969867B1 (de) | 2004-09-01 |
| DE69825976T2 (de) | 2005-09-01 |
| AU744302B2 (en) | 2002-02-21 |
| DE69825976D1 (de) | 2004-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199902818T2 (xx) | Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler. | |
| ES2160116T3 (es) | Modelo de equivalente de cornea producido in vitro. | |
| DE60334364D1 (de) | Behandlungsverfahren unter verwendung von anti-cd22-antikörpern | |
| GR890100652A (el) | Οφθαλμικη ραφη και οργανα για την εφαρμογη χρησεως της ραφης. | |
| DK0975672T3 (da) | Antistoffer til inhibition af blodkoagulation og fremgangsmåder til anvendelse heraf | |
| EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
| ATE224213T1 (de) | Implantat aus resorbierbaren phosphatglas | |
| DE60026691D1 (de) | Staphylococcus-antigene und impstoff | |
| TR200002731T2 (tr) | Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar | |
| DE60143517D1 (de) | Wiederherstellung der gelenken mit mesenchymalen stammzellen | |
| ATE368054T1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
| DK69890A (da) | Monoklonale antistoffer, der er reaktive med cachetin | |
| FI963101L (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
| NZ568769A (en) | Human monoclonal antibodies against CD20 | |
| FR07C0017I2 (fr) | Anticorps anti-vegf | |
| AU5055593A (en) | Antibodies specific for HIV | |
| MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
| DE69637890D1 (de) | Monoklonaler antikörper für die inhibierung von hiv-1-hüllgykoprotein-vermittelte membranfusion | |
| NO971341D0 (no) | Promoter for reseptor tyrosinkinase TIE | |
| DE69631972D1 (de) | Proliferationsinhibitor von endothellzellen und dessen verwendung | |
| FR2491334B1 (de) | ||
| ATE274920T1 (de) | Verwendung von anti-il-12 antikörpern bei transplantationsabstossungen | |
| TR200103432T2 (tr) | Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı. | |
| DK0840620T3 (da) | IL-8-antagonister til behandling af astma | |
| ATE124539T1 (de) | Immunogen und seine verwendung zur gewinnung von antikörpern gegen hba1c. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0969867 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |